HomeCompareMODVF vs MRK

MODVF vs MRK: Dividend Comparison 2026

MODVF yields 2.05% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MODVF wins by $28.10M in total portfolio value· pulled ahead in Year 2
10 years
MODVF
MODVF
● Live price
2.05%
Share price
$13.17
Annual div
$0.27
5Y div CAGR
94.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.16M
Annual income
$25,026,643.73
Full MODVF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — MODVF vs MRK

📍 MODVF pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMODVFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MODVF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MODVF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MODVF
Annual income on $10K today (after 15% tax)
$174.05/yr
After 10yr DRIP, annual income (after tax)
$21,272,647.17/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, MODVF beats the other by $21,264,050.46/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MODVF + MRK for your $10,000?

MODVF: 50%MRK: 50%
100% MRK50/50100% MODVF
Portfolio after 10yr
$14.11M
Annual income
$12,518,378.76/yr
Blended yield
88.72%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

MODVF
No analyst data
Price Target
$14.00
+6.3% upside vs current
Range: $14.00 — $14.00
Altman Z
1.8
Piotroski
7/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MODVF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMODVFMRK
Forward yield2.05%2.81%
Annual dividend / share$0.27$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR94.3%32.7%
Portfolio after 10y$28.16M$57.7K
Annual income after 10y$25,026,643.73$10,113.78
Total dividends collected$27.89M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst price target$14.00$128.54

Year-by-year: MODVF vs MRK ($10,000, DRIP)

YearMODVF PortfolioMODVF Income/yrMRK PortfolioMRK Income/yrGap
1$11,098$397.85$11,213$373.04$115.00MRK
2← crossover$12,676$801.77$12,667$512.06+$9.00MODVF
3$15,227$1,663.01$14,439$708.14+$788.00MODVF
4$19,920$3,627.41$16,640$988.16+$3.3KMODVF
5$29,932$8,617.23$19,432$1,394.07+$10.5KMODVF
6$55,539$23,512.40$23,057$1,992.90+$32.5KMODVF
7$138,651$79,223.64$27,889$2,894.79+$110.8KMODVF
8$507,497$359,141.11$34,518$4,286.29+$473.0KMODVF
9$2,930,095$2,387,073.02$43,912$6,494.35+$2.89MMODVF
10$28,161,846$25,026,643.73$57,714$10,113.78+$28.10MMODVF

MODVF vs MRK: Complete Analysis 2026

MODVFStock

Melcor Developments Ltd. operates as a real estate development company in the United States and Canada. The company operates through Community Development, Property Development, REIT, Investment Property, and Recreational Property segments. It develops, manages, and owns mixed-use residential communities, business and industrial parks, office buildings, retail centers, and golf courses. The company purchases and develops land to be sold as residential, industrial, and commercial lots; develops, constructs, and leases retail, office, and industrial properties; and owns and leases commercial, retail, and residential properties, as well as parking lots and land. It also owns and manages three 18-hole golf courses. Melcor Developments Ltd. was founded in 1923 and is headquartered in Edmonton, Canada.

Full MODVF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this MODVF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MODVF vs SCHDMODVF vs JEPIMODVF vs OMODVF vs KOMODVF vs MAINMODVF vs JNJMODVF vs ABBVMODVF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.